413 related articles for article (PubMed ID: 30606923)
21. Psoralidin, a prenylated coumestan, as a novel anti-osteoporosis candidate to enhance bone formation of osteoblasts and decrease bone resorption of osteoclasts.
Zhai Y; Li Y; Wang Y; Cui J; Feng K; Kong X; Chen L
Eur J Pharmacol; 2017 Apr; 801():62-71. PubMed ID: 28283388
[TBL] [Abstract][Full Text] [Related]
22. Genistein Improves Bone Healing via Triggering Estrogen Receptor Alpha-Mediated Expressions of Osteogenesis-Associated Genes and Consequent Maturation of Osteoblasts.
Wu GJ; Chen JT; Cherng YG; Chang CC; Liu SH; Chen RM
J Agric Food Chem; 2020 Sep; 68(39):10639-10650. PubMed ID: 32897066
[TBL] [Abstract][Full Text] [Related]
23. Silk proteins stimulate osteoblast differentiation by suppressing the Notch signaling pathway in mesenchymal stem cells.
Jung SR; Song NJ; Yang DK; Cho YJ; Kim BJ; Hong JW; Yun UJ; Jo DG; Lee YM; Choi SY; Park KW
Nutr Res; 2013 Feb; 33(2):162-70. PubMed ID: 23399667
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous delivery of BMP-2 factor and anti-osteoporotic drugs using hyaluronan-assembled nanocomposite for synergistic regulation on the behaviors of osteoblasts and osteoclasts in vitro.
Zhang Y; Hu Y; Luo Z; Shen X; Mu C; Cai K
J Biomater Sci Polym Ed; 2015; 26(5):290-310. PubMed ID: 25585099
[TBL] [Abstract][Full Text] [Related]
25. Eurycoma longifolia as a potential alternative to testosterone for the treatment of osteoporosis: Exploring time-mannered proliferative, differentiative and morphogenic modulation in osteoblasts.
Thu HE; Mohamed IN; Hussain Z; Shuid AN
J Ethnopharmacol; 2017 Jan; 195():143-158. PubMed ID: 27818256
[TBL] [Abstract][Full Text] [Related]
26. Methionine down-regulates TLR4/MyD88/NF-κB signalling in osteoclast precursors to reduce bone loss during osteoporosis.
Vijayan V; Khandelwal M; Manglani K; Gupta S; Surolia A
Br J Pharmacol; 2014 Jan; 171(1):107-21. PubMed ID: 24111943
[TBL] [Abstract][Full Text] [Related]
27. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of pharmaceuticals with a novel 50-hour animal model of bone loss.
Tomimori Y; Mori K; Koide M; Nakamichi Y; Ninomiya T; Udagawa N; Yasuda H
J Bone Miner Res; 2009 Jul; 24(7):1194-205. PubMed ID: 19257825
[TBL] [Abstract][Full Text] [Related]
29. Combined administration on You-Gui Yin and low-dose Raloxifene partially attenuates the bone loss in ovariectomized mice through the proliferation and osteogenic differentiation of bone marrow stromal cells.
Qi XY; Liu H; Bi DD; Wang XT; Guo YF; Hao T; Zhang BX; Wang XG; Han MH
Phytomedicine; 2019 Feb; 53():286-293. PubMed ID: 30668409
[TBL] [Abstract][Full Text] [Related]
30. Effects of Tinospora cordifolia (Menispermaceae) on the proliferation, osteogenic differentiation and mineralization of osteoblast model systems in vitro.
Abiramasundari G; Sumalatha KR; Sreepriya M
J Ethnopharmacol; 2012 May; 141(1):474-80. PubMed ID: 22449439
[TBL] [Abstract][Full Text] [Related]
31. Calcitonin Induces Bone Formation by Increasing Expression of Wnt10b in Osteoclasts in Ovariectomy-Induced Osteoporotic Rats.
Hsiao CY; Chen TH; Chu TH; Ting YN; Tsai PJ; Shyu JF
Front Endocrinol (Lausanne); 2020; 11():613. PubMed ID: 33013696
[TBL] [Abstract][Full Text] [Related]
32. Risedronate positively affects osteogenic differentiation of human mesenchymal stromal cells.
Casado-Díaz A; Santiago-Mora R; Dorado G; Quesada-Gómez JM
Arch Med Res; 2013 Jul; 44(5):325-34. PubMed ID: 23867791
[TBL] [Abstract][Full Text] [Related]
33. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
[TBL] [Abstract][Full Text] [Related]
34. New therapeutic targets for osteoporosis: beyond denosumab.
Lim V; Clarke BL
Maturitas; 2012 Nov; 73(3):269-72. PubMed ID: 22925430
[TBL] [Abstract][Full Text] [Related]
35. Effects of total lignans from Eucommia ulmoides barks prevent bone loss in vivo and in vitro.
Zhang R; Pan YL; Hu SJ; Kong XH; Juan W; Mei QB
J Ethnopharmacol; 2014 Aug; 155(1):104-12. PubMed ID: 24786573
[TBL] [Abstract][Full Text] [Related]
36. Comparative proteomic and metabolomic analysis reveal the antiosteoporotic molecular mechanism of icariin from Epimedium brevicornu maxim.
Xue L; Jiang Y; Han T; Zhang N; Qin L; Xin H; Zhang Q
J Ethnopharmacol; 2016 Nov; 192():370-381. PubMed ID: 27422162
[TBL] [Abstract][Full Text] [Related]
37. Osteoblast as a target of anti-osteoporotic treatment.
Corrado A; Sanpaolo ER; Di Bello S; Cantatore FP
Postgrad Med; 2017 Nov; 129(8):858-865. PubMed ID: 28770650
[TBL] [Abstract][Full Text] [Related]
38. 9-Demethoxy-medicarpin promotes peak bone mass achievement and has bone conserving effect in ovariectomized mice: Positively regulates osteoblast functions and suppresses osteoclastogenesis.
Goel A; Raghuvanshi A; Kumar A; Gautam A; Srivastava K; Kureel J; Singh D
Mol Cell Endocrinol; 2015 Aug; 411():155-66. PubMed ID: 25957087
[TBL] [Abstract][Full Text] [Related]
39. Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival.
Motyl KJ; McCauley LK; McCabe LR
J Cell Physiol; 2012 Apr; 227(4):1326-34. PubMed ID: 21604269
[TBL] [Abstract][Full Text] [Related]
40. Functions and mechanisms of green tea catechins in regulating bone remodeling.
Shen CL; Kwun IS; Wang S; Mo H; Chen L; Jenkins M; Brackee G; Chen CH; Chyu MC
Curr Drug Targets; 2013 Dec; 14(13):1619-30. PubMed ID: 24041336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
